Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Silymarin in Prevention of Contrast-Induced Nephropathy
IRCT2014051117648N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in contrast-induced nephropathy (CIN), sponsored by Isfahan University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
silymarin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT2014051117648N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014051117648N1.